Ashley Mansell

Ashley Mansell

Company: Bacainn Therapeutics/Hudson Institute of Medical Research

Job title: Senior Director of Research & Development/Principal Investigator

Seminars:

BT032: A Novel NLRP1 & NLRP3 Inhibitor to Treat Pulmonary Inflammation 11:30 am

BT032 is a novel first in class NLRP1 and NLRP3 inhibitor BT032 directly targets NLRP1 and NLRP3 activity BT032 reduces IAV-induced pulmonary inflammation in vivoRead more

day: Day 1 - Track B - Morning

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.